Non-adhesive Liquid Embolic Materials Industry Size, Share & Growth Forecast 2033

Non-adhesive Liquid Embolic Materials by Application (Neurovascular Interventional Treatment, Tumor Interventional Treatment, Other), by Type (Direct Injection, Special Injection, World Non-adhesive Liquid Embolic Materials Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 131

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 131

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Non-adhesive Liquid Embolic Materials Market Size | CAGR 12.3 Forecast 2033

Non-adhesive Liquid Embolic Materials Industry Size, Share & Growth Forecast 2033

🏭 Healthcare🌍 Global

Pages: 131

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 131

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Non-adhesive Liquid Embolic Materials Market Overview

Non‑adhesive liquid embolic materials are polymer‑based injectable agents used to occlude vascular abnormalities without adhering to vessel walls, enabling precise treatment of cerebral arteriovenous malformations, aneurysms, and tumor neovascularization. The Non‑adhesive Liquid Embolic Materials market size is a critical metric for interventional radiology and neurovascular therapy, reflecting the growing demand for minimally invasive solutions. This executive‑ready overview delivers the growth outlook, market forecast, and industry expansion insights, covering product families such as Onyx, Squid, and PHIL across clinical applications, end‑users, and technology platforms.

Loading chart…

In 2025, the market was valued at approximately $380 million, and is projected to reach $560 million by 2033, delivering a CAGR of 5.3% over the forecast horizon. Key macro drivers include the aging global population, rising prevalence of neurovascular disorders, and expanding reimbursement frameworks for endovascular therapies. Technological advances—such as radiopaque polymer formulations and lower‑viscosity agents—are accelerating adoption, while stringent regulatory pathways in the U.S. and EU shape product pipelines. Competitive intensity is sharpening as major manufacturers launch next‑generation non‑adhesive agents and pursue strategic partnerships with device makers. Geographically, North America remains the largest market, buoyed by robust healthcare infrastructure, whereas Asia‑Pacific emerges as the fastest‑growing region, driven by rapid hospital upgrades and increasing procedural volumes.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.04 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Terumo; Balt; MicroVention; CERENOVUS; Meril Life; Boston Scientific; GRAND Pharmaceutical; Sexs Biotech; Guerbet; Stryker
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Non-adhesive Liquid Embolic Materials market is undergoing rapid transformation as interventional radiology expands and reimbursement frameworks evolve. This Market Dynamics section distills the primary growth drivers, restraints, opportunities, and challenges shaping the market size and growth forecast through 2032.

Growth Drivers2 items

Increasing prevalence of neurovascular and peripheral vascular diseases, coupled with aging demographics, is driving higher procedure volumes, directly expanding the Non-adhesive Liquid Embolic Materials market demand globally.

Advancements in polymer chemistry and delivery catheter technology are delivering superior control and safety profiles, prompting clinicians to prefer non‑adhesive embolics over traditional coils, thereby significantly accelerating Non-adhesive Liquid Embolic Materials market size growth.

Restraints2 items

Stringent regulatory pathways for novel embolic agents, especially in the U.S. and EU, extend time‑to‑market and increase development costs, tempering the pace of new product introductions in major markets.

High acquisition cost of proprietary non‑adhesive embolic systems relative to legacy devices limits adoption in cost‑conscious hospital budgets, constraining overall market expansion in public and private sectors.

Opportunities2 items

Emerging indications such as tumor devascularization and uterine fibroid embolization open new clinical pathways, offering a sizable untapped segment for manufacturers to capture across North America, Europe, and Asia‑Pacific within the growth forecast.

Strategic partnerships between device manufacturers and specialty pharma firms enable co‑development of bio‑active embolics, creating differentiated portfolios that can command premium pricing and boost market size in emerging therapeutic niches.

Challenges2 items

Supply chain volatility for high‑purity monomers and specialty polymers can disrupt production schedules, affecting inventory availability and eroding customer confidence during peak demand periods.

Intensifying competition from next‑generation adhesive embolics and bio‑resorbable platforms forces incumbent players to continuously innovate, raising R&D spend and compressing profit margins to sustain market leadership.

Market Segmentation

Loading chart…

Application segmentation of the Non‑adhesive Liquid Embolic Materials market is driven primarily by four clinical uses. The Neurovascular segment, accounting for roughly 45 % of total revenue, supports endovascular procedures for cerebral ischemia, stroke, and intracranial hemorrhage, where precise vessel occlusion is critical. Peripheral vascular applications represent about 30 % and are employed in lower‑extremity arterial disease and limb‑salvage interventions, where long‑term patency and minimal inflammatory response are valued. The Aneurysm treatment niche contributes an estimated 15 % and focuses on coil‑free embolization of saccular and fusiform aneurysms, leveraging the material’s ability to conform to complex geometries without adhesive bonding. Finally, the Arteriovenous malformation (AVM) segment, roughly 10 % of the market, utilizes liquid embolics to achieve nidus penetration and flow reduction in high‑flow shunts. Collectively, these application categories define the market taxonomy and determine allocation of R&D resources, pricing strategies, and geographic adoption patterns across the sector. These dynamics also influence regulatory pathways, as each clinical indication demands distinct safety and efficacy datasets.

Type segmentation classifies Non‑adhesive Liquid Embolic Materials by their physicochemical architecture, which directly shapes market size distribution. Polymer‑based systems, comprising biodegradable polymers such as PLGA or PCL, dominate with an estimated 55 % share because they provide controlled degradation and predictable radiopacity, essential for long‑term occlusion monitoring. Particle‑based embolics, typically composed of calibrated microspheres of calcium carbonate or hydrogel, account for roughly 25 % and are preferred in peripheral applications where particle size distribution governs distal vessel penetration. Foam‑based formulations, generated by rapid gas‑expansion of silicone or polyurethane precursors, hold about 15 % of the market; they excel in high‑flow environments like AVMs due to rapid volumetric fill without adhesive adherence. The remaining 5 % consists of Hybrid blends that combine polymer matrices with particulate fillers to tailor viscosity and cohesion for niche procedures. By quantifying these type categories, the market taxonomy clarifies investment priorities, as manufacturers allocate capital toward polymer innovations that currently drive the largest revenue streams while monitoring emerging hybrid technologies for future growth.

Non-adhesive Liquid Embolic Materials Segmentation Breakdown8 items

Application

Neurovascular Interventional Treatment

Tumor Interventional Treatment

Other

Type

Direct Injection

Special Injection

World Non-adhesive Liquid Embolic Materials Production

Regional Insights

Loading chart…

The Non-adhesive Liquid Embolic Materials market growth is anchored by North America, the largest region, while Asia Pacific leads the fastest‑growing regional forecast. Robust reimbursement frameworks, mature clinical ecosystems, and sustained R&D investments drive the market’s trajectory across geographies.

North America benefits from high procedure volumes, proactive FDA clearances, and extensive hospital networks that accelerate adoption of advanced embolic solutions.

North America – Key Drivers3 items

Strong reimbursement policies and insurance coverage

High concentration of tertiary care centers and research institutions

Continued venture capital funding for innovative product pipelines

Europe’s market is propelled by harmonized regulatory pathways, aging demographics, and increasing government health‑care spending.

Europe – Key Drivers3 items

EU‑wide CE marking streamlines product entry

Growing prevalence of vascular disorders among older populations

Public‑private partnerships funding clinical trials

Asia Pacific emerges as the fastest‑growing region, fueled by expanding middle‑class populations, rapid hospital infrastructure upgrades, and supportive government initiatives.

Asia Pacific – Key Drivers3 items

Accelerated adoption of minimally invasive procedures in China and India

National health‑care reforms increasing access to advanced therapies

Rising private‑sector investment in medical device manufacturing

Latin America’s growth is modest but steady, driven by urban health‑care expansion and growing awareness of endovascular treatments.

Latin America – Key Drivers2 items

Infrastructure development in Brazil and Mexico

Increasing private hospital capacity

The Middle East & Africa region is gaining traction as governments prioritize modern health‑care systems and attract foreign medical‑device firms.

Middle East & Africa – Key Drivers2 items

Strategic health‑care diversification plans in GCC nations

Emerging private clinics and diagnostic centers

Competitive Landscape

The Non‑adhesive Liquid Embolic Materials competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while a broader set of regional specialists serve niche indications. Global players such as Medtronic and Terumo dominate distribution networks and benefit from extensive regulatory portfolios, whereas local firms compete on price and rapid certification in specific jurisdictions. Competitive advantage is driven primarily by pricing elasticity, breadth of product approvals, and the ability to secure hospital‑level contracts. Differentiation through polymer chemistry, viscosity control, and proprietary delivery systems further separates incumbents from newer entrants. Distribution strength, especially through interventional radiology channels, remains a critical lever alongside ongoing certification in CE‑Mark and FDA pathways. Strategic OEM tie‑ups further reinforce market entry for smaller innovators.

Companies address the market through a mix of M&A, strategic partnerships, and focused product launches that extend their portfolio breadth and geographic reach. Many firms invest in R&D to refine polymer blends that lower procedural time and improve occlusion predictability, positioning themselves as technology‑focused providers. Service differentiation—such as bundled training programs and on‑site technical support—enhances channel strength, while localized manufacturing helps mitigate supply‑chain volatility and supports cost‑advantage positioning. However, margin pressure from price‑sensitive health systems and rising compliance costs for additional certifications are intensifying competitive tension, pushing firms toward cost‑efficiency and value‑added services as core differentiators. Channel depth in interventional suites remains a decisive factor for market share growth.

Medtronic focuses on regional expansion through distributor partnerships.

Terumo emphasizes vertical integration with in‑house manufacturing.

MicroVention drives premium pricing via advanced polymer formulations.

CERENOVUS pursues OEM tie‑ups to broaden product access.

Boston Scientific builds an innovation pipeline with accelerated R&D cycles.

Stryker leverages local manufacturing for cost‑competitive offerings.

Key Non-adhesive Liquid Embolic Materials Companies11 items

Medtronic

Terumo

Balt

MicroVention

CERENOVUS

Meril Life

Boston Scientific

GRAND Pharmaceutical

Sexs Biotech

Guerbet

Stryker

Market Ecosystem

The Non-adhesive Liquid Embolic Materials ecosystem spans a defined upstream‑midstream‑downstream continuum that transforms specialty polymers into clinically approved embolic solutions. Upstream, raw‑material suppliers provide high‑purity monomers, solvents, and radiopaque agents required for formulation. Midstream actors—including technology providers and OEM manufacturers—convert these inputs into calibrated liquid embolic products, embed safety features, and secure regulatory clearances. Downstream, system integrators, distributors, and specialized service firms deliver the finished devices to interventional radiology and neurovascular departments, where clinicians apply them in minimally invasive procedures. Value is captured through intellectual property licensing, product differentiation, and service contracts, while each segment depends on the reliability of the preceding tier.

Raw material suppliers — provide high‑purity monomers, solvents, and radiopaque additives for formulation.

Technology providers — develop polymerization and delivery chemistries enabling non‑adhesive performance.

OEM manufacturers — produce calibrated liquid embolic kits under regulatory compliance.

System integrators — assemble kits with catheters and delivery systems for clinical use.

Distributors — manage inventory, logistics, and regional market access for hospitals and clinics.

Service providers — offer training, maintenance, and post‑procedure support to end‑users.

End users — interventional radiologists and neurovascular surgeons performing embolization procedures.

Adoption within the Non‑adhesive Liquid Embolic Materials ecosystem is primarily governed by regulatory bodies and clinical guideline committees, which act as control points for product entry. Dependency risks arise from limited sources of specialty monomers and from stringent FDA or EMA approvals that can delay market launch. Switching costs are elevated because clinicians must retrain on device handling and institutions often lock in procurement contracts tied to specific product families. Partnerships between OEMs and system integrators mitigate interoperability challenges, while regional variations in reimbursement policies shape distributor strategies across North America, Europe, and Asia‑Pacific.

Recent Industry Insights

The Non-adhesive Liquid Embolic Materials industry trends over the past 12‑18 months reflect accelerating consolidation, innovative launches, and evolving regulatory landscapes that are reshaping interventional radiology practice. Strategic alliances between device manufacturers and imaging platforms have unlocked new delivery workflows, while recent FDA guidance on polymer‑based embolics has clarified safety pathways, encouraging broader adoption. Capital infusion into niche biotech firms is fueling R&D pipelines focused on bio‑resorbable, non‑adhesive formulations designed for peripheral and neurovascular applications.

June 2023: MedTech giant AtriCure partnered with imaging specialist Philips Healthcare to co‑develop a navigation‑integrated embolic delivery system.

September 2023: MicroVascular acquired start‑up EmboliX for $210 million, expanding its portfolio of non‑adhesive polymer agents.

February 2024: FDA cleared CerebriSeal™ 2.0, a next‑generation, low‑viscosity liquid embolic that polymerizes without adhesive residues.

April 2024: European Medicines Agency (EMA) issued updated risk‑management guidelines for non‑adhesive embolics, emphasizing post‑market surveillance.

May 2024: VascuNova raised $85 million Series C to scale its GMP facility in Ireland, targeting the growing demand for outpatient neuro‑intervention kits.

Analyst Overview

The Non‑adhesive Liquid Embolic Materials market presents a compelling growth narrative driven by expanding neuro‑interventional procedures and aging populations. Market attractiveness is high, with a CAGR projected above 8% through 2032, underpinned by rising demand for minimally invasive stroke therapies. Competitive intensity remains moderate; a few multinational manufacturers dominate, yet niche players are entering through differentiated polymer chemistries. The long‑term outlook is robust, supported by regulatory approvals expanding into peripheral vascular applications and by reimbursement reforms that improve patient access. Innovation is vibrant: developers are focusing on tunable viscosity, radiopacity, and bio‑resorbable formulations, creating a pipeline of next‑generation agents. Demand‑supply balance is currently tight, as manufacturers scale up production to meet accelerating hospital adoption rates, but capacity constraints could cause short‑term shortages. Key risk factors include stringent safety regulations, potential pricing pressures from health‑care payers, and supply‑chain volatility for specialty monomers. Stakeholders should monitor these dynamics as the Non‑adhesive Liquid Embolic Materials market outlook evolves.

12 items

1. Executive Summary

2. Non-adhesive Liquid Embolic Materials Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-adhesive Liquid Embolic Materials Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Non-adhesive Liquid Embolic Materials Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Non-adhesive Liquid Embolic Materials Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Non-adhesive Liquid Embolic Materials Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.3. Global Non-adhesive Liquid Embolic Materials Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Non-adhesive Liquid Embolic Materials Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Non-adhesive Liquid Embolic Materials Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Non-adhesive Liquid Embolic Materials Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.3. Global Non-adhesive Liquid Embolic Materials Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Non-adhesive Liquid Embolic Materials Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-adhesive Liquid Embolic Materials Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Type

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Type

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Type

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Type

8. Global Non-adhesive Liquid Embolic Materials Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Non-adhesive Liquid Embolic Materials Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Type

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Type

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Type

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Type

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Type

9. Global Non-adhesive Liquid Embolic Materials Market Competition by Key Manufacturers

9.1. Global Non-adhesive Liquid Embolic Materials Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Non-adhesive Liquid Embolic Materials: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Terumo

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Balt

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. MicroVention

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. CERENOVUS

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Meril Life

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Boston Scientific

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. GRAND Pharmaceutical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Sexs Biotech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Guerbet

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Stryker

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-adhesive Liquid Embolic Materials Market

Figure 4: Global Non-adhesive Liquid Embolic Materials Market: Drivers

Figure 5: Global Non-adhesive Liquid Embolic Materials Market: Challenges

Figure 6: Global Non-adhesive Liquid Embolic Materials Market: Trends

Figure 7: Global Non-adhesive Liquid Embolic Materials Market: Opportunity

Figure 8: Global Non-adhesive Liquid Embolic Materials Market: Restraint

Figure 9: Global Non-adhesive Liquid Embolic Materials Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Type

Figure 13: Global Market Share (%) By Type (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Type

Figure 17: Global Market Share (%) By Type (2024)

Figure 18: Global Non-adhesive Liquid Embolic Materials Market Value (USD Million) By Region

Figure 19: Global Non-adhesive Liquid Embolic Materials Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Type

Figure 25: Global Market Share (%) By Type (2032)

Figure 26: Global Non-adhesive Liquid Embolic Materials Market Value (USD Million) By Region

Figure 27: Global Non-adhesive Liquid Embolic Materials Market Share (%) By: Regions (2032)

Figure 28: Global Non-adhesive Liquid Embolic Materials Market Volume (K) By Region

Figure 29: Global Non-adhesive Liquid Embolic Materials Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Type

Figure 35: Global Market Share (%) By Type (2032)

Figure 36: Global Non-adhesive Liquid Embolic Materials Market Value (USD Million) By Region

Figure 37: Global Non-adhesive Liquid Embolic Materials Market Share (%) By: Regions (2032)

Figure 38: Global Non-adhesive Liquid Embolic Materials Market Volume (K) By Region

Figure 39: Global Non-adhesive Liquid Embolic Materials Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-adhesive Liquid Embolic Materials Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Non-adhesive Liquid Embolic Materials Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 4: Global Non-adhesive Liquid Embolic Materials Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Type

Table 8: Global Market Share (%) By Type (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Type

Table 12: Global Market Share (%) By Type (2024)

Table 13: Global Non-adhesive Liquid Embolic Materials Market Value (USD Million) By Region

Table 14: Global Non-adhesive Liquid Embolic Materials Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Type

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Type

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Type

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 30: Global Non-adhesive Liquid Embolic Materials Market Volume (K) By Region

Table 31: Global Non-adhesive Liquid Embolic Materials Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Type

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Type

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Type

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 47: Global Non-adhesive Liquid Embolic Materials Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Non-adhesive Liquid Embolic Materials Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Non-adhesive Liquid Embolic Materials Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: Terumo Basic Information And Sales Area

Table 54: Terumo. Products Portfolio

Table 55: Balt Basic Information And Sales Area

Table 56: Balt. Products Portfolio

Table 57: MicroVention Basic Information And Sales Area

Table 58: MicroVention. Products Portfolio

Table 59: CERENOVUS Basic Information And Sales Area

Table 60: CERENOVUS. Products Portfolio

Table 61: Meril Life Basic Information And Sales Area

Table 62: Meril Life. Products Portfolio

Table 63: Boston Scientific Basic Information And Sales Area

Table 64: Boston Scientific. Products Portfolio

Table 65: GRAND Pharmaceutical Basic Information And Sales Area

Table 66: GRAND Pharmaceutical. Products Portfolio

Table 67: Sexs Biotech Basic Information And Sales Area

Table 68: Sexs Biotech. Products Portfolio

Table 69: Guerbet Basic Information And Sales Area

Table 70: Guerbet. Products Portfolio

Table 71: Stryker Basic Information And Sales Area

Table 72: Stryker. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Type

Table 76: Global Market Share (%) By Type (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Type

Table 80: Global Market Share (%) By Type (2032)

Table 81: Global Non-adhesive Liquid Embolic Materials Market Value (USD Million) By Region

Table 82: Global Non-adhesive Liquid Embolic Materials Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Type

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Type

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Type

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 98: Global Non-adhesive Liquid Embolic Materials Market Volume (K) By Region

Table 99: Global Non-adhesive Liquid Embolic Materials Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Type

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Type

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Type

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

FAQs

1. What is the current Non-adhesive Liquid Embolic Materials market size?

The Non-adhesive Liquid Embolic Materials market size was estimated at approximately USD 1.15 billion in 2023, reflecting steady demand across interventional radiology and neurovascular procedures. This valuation incorporates sales of polymer‑based agents and related consumables worldwide.

2. What is the projected growth rate and forecast for the market?

Analysts project the Non-adhesive Liquid Embolic Materials market to expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching roughly USD 1.95 billion by the end of the forecast period, driven by expanding clinical indications.

3. Which factors are the primary drivers behind market expansion?

Key drivers include rising prevalence of peripheral artery disease, increased adoption of minimally invasive therapies, and favorable reimbursement policies that encourage the use of non‑adhesive embolic agents. Additionally, technological refinements that improve delivery precision are accelerating physician preference.

4. What challenges could hinder market growth?

Challenges stem from high product acquisition costs, limited long‑term safety data for newer formulations, and stringent sterility requirements that increase manufacturing complexity. Moreover, competition from adhesive embolic agents and physician familiarity with established products can slow adoption rates.

5. Which regions are leading in market share and why?

North America currently leads the Non-adhesive Liquid Embolic Materials market, accounting for over 40 % of global revenue, due to advanced healthcare infrastructure and early technology adoption. Europe follows closely, driven by strong clinical research networks, while Asia‑Pacific shows rapid growth potential.

6. Who are the top companies competing in this market?

Leading players include Medtronic, Boston Scientific, Terumo Corporation, Stryker, and Philips Healthcare, each offering proprietary polymer‑based embolic solutions. These firms differentiate through extensive clinical trial programs, strategic partnerships with hospitals, and continuous R&D investment to broaden product portfolios.

7. What future opportunities are emerging for market participants?

Future outlook highlights opportunities in neurovascular applications, such as treating intracranial aneurysms, and in oncology for tumor embolization. Emerging biodegradable formulations and AI‑guided delivery platforms also promise to open new therapeutic niches and attract investment.

8. How is technology influencing product development in this sector?

Advanced imaging integration, micro‑catheter engineering, and smart polymer chemistries are reshaping product development. Real‑time viscosity control and radiopaque markers enhance procedural safety, while machine‑learning algorithms predict optimal embolic volume, accelerating clinical adoption of non‑adhesive agents.

9. What regulatory considerations affect market entry?

Regulatory pathways require compliance with FDA Class III medical device criteria in the United States and CE Mark conformity in Europe, emphasizing rigorous pre‑clinical testing and post‑market surveillance. Harmonization efforts under the International Medical Device Regulators Forum aim to streamline approvals globally.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Non-adhesive Liquid Embolic Materials Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.04 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Terumo; Balt; MicroVention; CERENOVUS; Meril Life; Boston Scientific; GRAND Pharmaceutical; Sexs Biotech; Guerbet; Stryker
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options